A consortium of investors including Hanwha Corporate Venture Capital, OIC, Catalus Capital and Ascent Funds completed a $50m investment in Forge Nano, a biotechnology company. “This funding milestone allows us to fulfill the customer demand that already exists for our advanced batteries and equipment. As we move to grow our Atomic Armor technology in the Lithium-ion market, we are excited to finally be able to internally provide a finished battery solution at scale. In the past 4 years, we have seen dramatic revenue growth every year. With this new funding, we now aim to significantly accelerate this growth," Paul Lichty, Forge Nano CEO.